Medical News

  • Early EEG helps predict cardiac arrest outcomes in comatose
    (HealthDay)—Early electroencephalography (EEG) reliably predicts the outcome of comatose patients after cardiac arrest, according to a study recently published in the Annals of Neurology. Read more »
  • Test shown to improve accuracy in identifying precancerous pancreatic cysts
    In a proof-of-concept study, an international scientific team led by Johns Hopkins Kimmel Cancer Center researchers has shown that a laboratory test using artificial intelligence tools has the potential to more accurately sort out which people with pancreatic cysts will go on to develop pancreatic cancers. Read more »
  • Rare inherited enzyme disorder yields insight into fibrosis
    What can a family of rare inherited disorders teach scientists about more common health problems like fibrosis? Plenty, based on research led by St. Jude Children's Research Hospital scientists that appears today in the journal Science Advances. Read more »
  • HIV vaccine nears clinical trial following new findings
    A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide similar protection as its original version. Read more »
  • Wake up your breakfast with delicious whole grains
    (HealthDay)—If you're looking to change up that sugary bowl of cold cereal, quinoa and amaranth are nutritious alternatives. Read more »
  • Rituximab noninferior to cyclosporine in membranous nephropathy
    (HealthDay)—In patients with membranous nephropathy at high risk for progressive disease, rituximab is noninferior to cyclosporine in inducing complete or partial remission of proteinuria at 12 months and is superior in maintaining proteinuria remission up to 24 months, according to a study published in the July 4 issue of the New England Journal of Medicine. Read more »
  • Mayo Clinic Q&A: Heart disease and kidney disease—what's the connection?
    Dear Mayo Clinic: My 78-year-old mother had a heart attack three weeks ago. She was feeling better for a bit, but became ill again and was told she has an acute kidney injury. Are the two conditions somehow related? Is she at higher risk for more kidney and heart problems after this? Read more »
  • Autism largely caused by genetics, not environment: Study
    (HealthDay)—The largest study of its kind, involving more than 2 million people across five countries, finds that autism spectrum disorders are 80% reliant on inherited genes. Read more »
  • Continuous anticoagulants and cold snare polypectomy noninferior
    (HealthDay)—For patients with subcentimeter colorectal polyps receiving oral anticoagulants, continuous administration of anticoagulants (CA) with cold snare polypectomy (CSP) is noninferior to periprocedural heparin bridging (HB) with hot snare polypectomy (HSP) for polypectomy-related major bleeding, according to a study published online July 16 in the Annals of Internal Medicine. Read more »
  • Dutch airline KLM under fire for breastfeeding cover-up rule
    Dutch airline KLM faced criticism Wednesday for policies that "shame women's bodies" after a breastfeeding mother said she was told to cover up in case other passengers were offended. Read more »
  • Buzz off: breakthrough technique eradicates mosquitoes
    A breakthrough technique harnessing two methods to target disease-carrying mosquitoes was able to effectively eradicate buzzing biters in two test sites in China, according to research published on Thursday. Read more »
  • Many patients with depression do not need a psychiatrist
    (HealthDay)—Primary care doctors can detect and treat most cases of depression, according to a study published in the July/August issue of the Annals of Family Medicine. Read more »
  • Pregnancies persist among women taking acne medication known to cause birth defects
    Isotretinoin (also known by its former brand name as Accutane or Roaccutane) is an extremely effective acne medication that can help patients whose severe acne has not responded to other drugs. But the drug is also a potent teratogen—if a woman takes isotretinoin while pregnant, even for a short period of time, the risk of severe birth defects is high. In 2006, the U.S. Federal Drug Administration (FDA) imposed a special restricted distribution program, known as iPLEDGE, which has stringent, recurring requirements for patients, prescribing physicians and dispensing pharmacists. But despite the substantial imposition of iPLEDGE on patients and clinicians, the extent to which it has reduced pregnancy and other adverse effects has been unknown. In a new study, investigators at Brigham and Women's Hospital evaluated the frequency of reported pregnancies and pregnancy-related adverse events among women taking isotretinoin. In a paper published in JAMA Dermatology, the team reports that although the number of pregnancies has decreased, pregnancies among women taking isotretinoin have continued to persist even after the implementation of iPLEDGE. Read more »
  • Neighborhood environment and health
    It is well understood that urban black males are at a disproportionately high risk of poor health outcomes. But little is known about how the neighborhood environments where these men live contribute to their health. Read more »
  • At-home support helps stroke patients adjust after hospital stay
    Michigan State University researchers have found that many stroke patients feel unprepared when discharged from the hospital. Their caregivers feel the same. Read more »
  • Crunching the numbers of cancer metastasis
    In metastasis, cancer cells break away from the original tumor and take root in another region of the body by entering the blood stream. In order to spread, metastatic cells cross over the endothelium—a barrier of endothelial cells lining the circulatory system that controls the passing of materials into and out of the blood stream—a behavior not as easily accomplished by non-metastatic cells. Read more »
  • Can gut infection trigger Parkinson's disease?
    A new study by Montreal scientists published today in Nature demonstrates that a gut infection can lead to a pathology resembling Parkinson's disease (PD) in a mouse model lacking a gene linked to the human disease. Read more »
  • Making cancer stem cells visible to the immune system
    Leukemia stem cells protect themselves against the immune defense by suppressing a target molecule for killer cells. This protective mechanism can be tricked with drugs. In the journal Nature, scientists from Basel, Tübingen and Heidelberg describe the new therapeutic approaches that can possibly be derived from these results. Read more »
  • Study pinpoints cell types affected in brains of multiple sclerosis patients
    Scientists have discovered that a specific brain cell known as a 'projection neuron' has a central role to play in the brain changes seen in multiple sclerosis (MS). The research, published today in Nature, shows that projection neurons are damaged by the body's own immune cells, and that this damage could underpin the brain shrinkage and cognitive changes associated with MS. These new findings provide a platform for specific new MS therapies that target damaged brain cells to be developed. Read more »
  • Researchers identify possible drug target for deadly heart condition
    A genetic mutation linked to dilated cardiomyopathy, a dangerous enlargement of the heart's main pumping chamber, activates a biological pathway normally turned off in healthy adult hearts, according to a study by researchers at the Stanford University School of Medicine. Read more »